Synbio International, Inc.
SYIN
$0.002
$0.000211.11%
| 06/30/2024 | 03/31/2024 | 03/31/2007 | 12/31/2006 | 09/30/2006 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 7.80K | 27.70K | 40.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 7.80K | 27.70K | 40.70K |
| Cost of Revenue | -- | -- | 6.70K | 25.10K | 35.50K |
| Gross Profit | -- | -- | 1.10K | 2.60K | 5.20K |
| SG&A Expenses | 60.70K | 60.70K | 86.10K | 88.70K | 71.80K |
| Depreciation & Amortization | 7.00K | 7.00K | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 67.60K | 67.60K | 92.80K | 113.80K | 107.30K |
| Operating Income | -67.60K | -67.60K | -85.00K | -86.10K | -66.60K |
| Income Before Tax | -86.90K | -86.90K | -85.00K | -86.10K | -66.60K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -86.90K | -86.90K | -85.00K | -86.10K | -66.60K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -86.90K | -86.90K | -85.00K | -86.10K | -66.60K |
| EBIT | -67.60K | -67.60K | -85.00K | -86.10K | -66.60K |
| EBITDA | -60.70K | -60.70K | -82.70K | -82.70K | -63.20K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | -- | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 351.32M | 351.32M | 102.35M | 96.95M | 84.69M |
| Average Diluted Shares Outstanding | 351.32M | 351.32M | 102.35M | 96.95M | 84.69M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
